Q1 2022 Holdings
Filed 2022-05-16 | 145 holdings | $923.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Boston Scientific Corp(BSX) | COM | 101137107 | $203.7M | 4,599,500 | 22.0% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $148.4M | 915,600 | 16.1% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $127.0M | 1,647,030 | 13.7% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $117.0M | 6,073,850 | 12.7% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $70.2M | 3,196,876 | 7.6% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $53.5M | 169,800 | 5.8% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $40.8M | 4,180,768 | 4.4% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $29.7M | 21,642,975 | 3.2% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $27.2M | 1,579,900 | 2.9% |
| Biogen Inc(BIIB) | COM | 09062X103 | $24.8M | 117,900 | 2.7% |
| Adagio Therapeutics Inc(IVVD) | COM | 00534A102 | $23.1M | 5,056,000 | 2.5% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $13.8M | 406,100 | 1.5% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $11.4M | 6,943,654 | 1.2% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $10.5M | 621,700 | 1.1% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $7.0M | 670,787 | 0.8% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $5.7M | 2,124,975 | 0.6% |
| Acutus MED Inc(AFIB) | COM | 005111109 | $3.7M | 2,648,386 | 0.4% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $1.2M | 577,509 | 0.1% |
| Springworks Therapeutics Inc | COM | 85205L107 | $340.2K | 6,028,307 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $231.1K | 2,196,555 | 0.0% |
| Pfizer Inc(PFE) | COM | 717081103 | $202.2K | 3,905,500 | 0.0% |
| Theseus Pharmaceuticals Inc | COM | 88369M101 | $196.5K | 17,041,668 | 0.0% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $190.4K | 2,607,700 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $166.1K | 381,700 | 0.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $161.2K | 534,200 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $150.0K | 294,200 | 0.0% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $148.7K | 7,447,141 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $142.7K | 6,855,423 | 0.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $135.3K | 13,944,680 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $134.1K | 1,630,500 | 0.0% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $123.8K | 1,051,300 | 0.0% |
| Stryker Corporation(SYK) | COM | 863667101 | $122.2K | 457,100 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $110.4K | 6,633,006 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $104.4K | 400,200 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $96.2K | 667,700 | 0.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $91.3K | 1,679,417 | 0.0% |
| Guardant Health Inc(GH) | COM | 40131M109 | $87.8K | 1,325,400 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $85.3K | 719,034 | 0.0% |
| Tricida Inc(1T7) | COM | 89610F101 | $84.5K | 10,280,947 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $82.1K | 875,515 | 0.0% |
| Ikena Oncology Inc | NONVOTING | 000000000 | $77.1K | 11,895,652 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $76.7K | 149,900 | 0.0% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $71.2K | 120,600 | 0.0% |
| Si-Bone Inc(SIBN) | COM | 825704109 | $70.9K | 3,139,247 | 0.0% |
| Prelude Therapeutics Inc(PRLD) | COM | 74065P101 | $69.3K | 10,039,691 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $64.9K | 1,595,385 | 0.0% |
| Sierra Oncology Inc | COM NEW | 82640U404 | $63.0K | 1,964,770 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $54.6K | 1,576,600 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $54.2K | 2,018,950 | 0.0% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $54.0K | 628,300 | 0.0% |